Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

Share Price is delayed by 15 minutes
Get Live Data
13.75    -0.375 (-2.65%)
Bid:
13.50
Ask:
14.00
Spread: 0.50 (3.704%)
Market Cap: £61.76m
CREO Live PriceLast checked at - London Stock Exchange

Intraday Creo Medical Share Chart

Transaction in Own Shares

19 Dec 2008 16:33

RNS Number : 5267K
China Real Estate Opportunities PLC
19 December 2008
 

China Real Estate Opportunities plc

Transaction in own securities

The Board of China Real Estate Opportunities plc ("CREO" or "the Company") announces that on 19 December 2008, the Company purchased 1,000,000 of its own ordinary shares of nil par value at a price of 205p per share for cancellation.

The purchase represents 1.95 per cent. of the shares in issue and is pursuant to the resolutions passed at an Extraordinary General Meeting of the Company held on 3 December 2008. 

The Concert Party (as defined in the Notice of the Extraordinary General Meeting) is interested in 23,976,653 ordinary shares, representing 47.76 per cent. of the Company's revised issued share capital. 

The purchase and cancellation will reduce the number of shares in issue to 50,203,038

Contact:

CREO

Ray Horney, Chairman

Tel: + 44 (0) 1273 775225

Sarah Moriarty, Investor Relations 

Tel: +353 1 6189455

Matrix Corporate Capital LLP 

Paul Fincham 

+ 44 (0) 20 3206 7000

Davy

Des Carville

Tel: +353 1 679 6363

Bankside Consultants

Simon Rothschild, Oliver Winters

Tel: + 44 (0) 20 7367 8888

Murray Consultants

Ed Micheau

Tel: + 353 1 498 0300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSFFFFMUSASEDE
Date   Source Headline
8th Dec 200610:00 amRNSSuspension- China Real Estate
27th Sep 20069:30 amRNSInterim Results
25th Sep 200611:21 amRNSRe: Grant of share options
4th Jan 200611:02 amRNSStmnt re Share Price Movement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.